← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Children'S Hospital Of Orange County
Orange, CA
$15,068,634
Total funding
13
Grants
Funding over time
peak $3.5M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$9,573,977 · 9
CDC$3,981,145 · 2
DOD$1,474,039 · 1
FDA$39,473 · 1
By mechanism
R01$7,663,553 · 7
U01$3,981,145 · 1
—$1,474,039 · 1
T15$1,109,397 · 1
R21$840,500 · 2
U27$0 · 1
Investigators at Children'S Hospital Of Orange County
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Emerging Leaders
6–10 yrs in
Not enough data
Largest grants
PHARMACOLOGICAL TREATMENT TO PREVENT PEDIATRIC HYDROCEPHALUS$1,474,039
· FY2025 · Defense Health Agency
Cardiovascular Structure and Function in the Mucopolysaccharidoses$852,280
R01 · FY2025 · HL
Preventing Bleeding Disorder Complications thru Hemophilia Tx Ctrs in Region IX$850,000
U01 · FY2006 · DD
Preventing Bleeding Disorder Complications thru Hemophilia Tx Ctrs in Region IX$850,000
U01 · FY2007 · DD
Preventing Bleeding Disorder Complications thru Hemophilia Tx Ctrs in Region IX$799,000
U01 · FY2008 · DD
Preventing Bleeding Disorder Complications thru Hemophilia Tx Ctrs in Region IX$799,000
U01 · FY2009 · DD
Combination Gene Therapy for Treatment of Canine Mucopolysaccharidosis Type I$708,768
R01 · FY2023 · HD
Preventing Bleeding Disorder Complications thru Hemophilia Tx Ctrs in Region IX$683,145
U01 · FY2010 · DD
An Open Resource for Autism iPSCs and Their Derivatives$617,911
R01 · FY2009 · HD
Combination Gene Therapy for Treatment of Canine Mucopolysaccharidosis Type I$613,028
R01 · FY2024 · HD
Neuroimaging and Neuropsychological Outcomes Spanning from 0 to 27 years in Individuals Born Very Preterm$607,274
R01 · FY2025 · HD
An Open Resource for Autism iPSCs and Their Derivatives$562,927
R01 · FY2012 · HD
An Open Resource for Autism iPSCs and Their Derivatives$561,413
R01 · FY2010 · HD
An Open Resource for Autism iPSCs and Their Derivatives$561,337
R01 · FY2011 · HD
Combination Gene Therapy for Treatment of Canine Mucopolysaccharidosis Type I$546,164
R01 · FY2025 · HD
An Open Resource for Autism iPSCs and Their Derivatives$545,118
R01 · FY2013 · HD
Mouse Genes that Regulate Hemostasis and/or Thrombosis$425,000
R01 · FY2011 · HL
PATHOGENESIS OF AUTOIMMUNE THROMBOCYTOPENIA$292,000
R01 · FY2001 · HL
PATHOGENESIS OF AUTOIMMUNE THROMBOCYTOPENIA$292,000
R01 · FY2000 · HL
PATHOGENESIS OF AUTOIMMUNE THROMBOCYTOPENIA$261,584
R01 · FY2002 · HL